ATE498020T1 - 5t4 rna in plasma und serum als marker für neoplastische erkrankungen - Google Patents

5t4 rna in plasma und serum als marker für neoplastische erkrankungen

Info

Publication number
ATE498020T1
ATE498020T1 AT01964280T AT01964280T ATE498020T1 AT E498020 T1 ATE498020 T1 AT E498020T1 AT 01964280 T AT01964280 T AT 01964280T AT 01964280 T AT01964280 T AT 01964280T AT E498020 T1 ATE498020 T1 AT E498020T1
Authority
AT
Austria
Prior art keywords
rna
serum
plasma
marker
neoplastic diseases
Prior art date
Application number
AT01964280T
Other languages
English (en)
Inventor
Michael Kopreski
Christopher Gocke
Original Assignee
Oncomedx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/649,371 external-priority patent/US6794135B1/en
Application filed by Oncomedx Inc filed Critical Oncomedx Inc
Application granted granted Critical
Publication of ATE498020T1 publication Critical patent/ATE498020T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01964280T 2000-08-28 2001-08-21 5t4 rna in plasma und serum als marker für neoplastische erkrankungen ATE498020T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/649,371 US6794135B1 (en) 1996-03-26 2000-08-28 Method for detection of 5T4 RNA in plasma or serum
PCT/US2001/026119 WO2002018645A2 (en) 2000-08-28 2001-08-21 5t4 rna in plasma and serum as a marker for neoplastic disease

Publications (1)

Publication Number Publication Date
ATE498020T1 true ATE498020T1 (de) 2011-02-15

Family

ID=24604503

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964280T ATE498020T1 (de) 2000-08-28 2001-08-21 5t4 rna in plasma und serum als marker für neoplastische erkrankungen

Country Status (6)

Country Link
US (2) US20050260594A1 (de)
EP (1) EP1354060B1 (de)
AT (1) ATE498020T1 (de)
AU (1) AU2001285157A1 (de)
DE (1) DE60144027D1 (de)
WO (1) WO2002018645A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060121477A1 (en) * 2002-09-12 2006-06-08 Abraham Hochberg Method for detection of micro-metastasis
US8252529B2 (en) * 2008-06-12 2012-08-28 The Invention Science Fund I, Llc Methods for collecting and detecting oligonucleotides
US8614057B2 (en) * 2008-06-12 2013-12-24 The Invention Science Fund I, Llc Methods for collecting and detecting oligonucleotides
US8252528B2 (en) * 2008-06-12 2012-08-28 The Invention Science Fund I, Llc Methods, compositions, and kits for collecting and detecting oligonucleotides
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869053A (en) * 1988-03-04 1999-02-09 Cancer Research Campaign Technology, Ltd. 5T4 antigen from human trophoblasts
EP0336562B1 (de) * 1988-03-04 1995-06-14 Cancer Research Campaign Technology Ltd. Antigene
WO1993007293A1 (en) * 1991-10-04 1993-04-15 The Children's Hospital Of Philadelphia Detecting digeorge syndrome mutations
US6329179B1 (en) * 1996-03-26 2001-12-11 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US5939262A (en) * 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
GB9704444D0 (en) * 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
US6664056B2 (en) * 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
FR2839015A1 (fr) * 2002-04-29 2003-10-31 Conception & Dev Michelin Sa Bandage flexible non pneumatique
WO2004065629A1 (en) * 2003-01-17 2004-08-05 The Chinese University Of Hong Kong Circulating mrna as diagnostic markers for pregnancy-related disorders

Also Published As

Publication number Publication date
US20080200410A1 (en) 2008-08-21
EP1354060B1 (de) 2011-02-09
DE60144027D1 (de) 2011-03-24
EP1354060A2 (de) 2003-10-22
US20050260594A1 (en) 2005-11-24
AU2001285157A1 (en) 2002-03-13
WO2002018645A3 (en) 2003-07-24
WO2002018645A2 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
WO2002018652A3 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
WO2002054081A3 (en) Proteins, genes and their use for diagnosis and treatment of kidney response
DE69933989D1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
ATE518477T1 (de) Fluoreszenzvermittelte molekulartomographie
WO2003028531A3 (en) Detection of tumor rna in plasma and serum
WO2002059604A3 (en) Diagnosis and treatment of multiple sclerosis
DE602006015966D1 (de) Verfahren zur vorhersage und überwachung einer unmittelbaren reaktion auf eine krebstherapie
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
DE50103907D1 (de) Verwendungen der Aldose-1-Epimerase (Mutarotase) für die Diagnose von Entzündungserkrankungen und Sepsis
WO2003001183A3 (en) Methods for detecting and monitoring cox-2 rna in plasma and serum
IL151448A0 (en) Proteins
ATE498020T1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
WO2003048734A3 (en) Detection of matrix metalloproteinase rna in plasma and serum
WO2001062785A3 (en) Protein and gene and their use for diagnosis and treatment of schizophrenia
AU2842901A (en) Use of contrast agents in the manufacture of diagnostic agent for the visualisation of the intestinal lumen
WO2002072752A3 (en) Forms of prostate specific antigens and methods for their detection
WO2001069261A3 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
WO2000073338A8 (en) Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
DE602004029477D1 (de) Methode zur detektion und beobachtung von krankheiten durch analyse von an den zellen gebundenen nukleinsäuren
ATE335806T1 (de) Diagnosisverfahren für whipples krankheit
ATE420210T1 (de) Diagnose des brustkrebsrisikos
AU2001261674A1 (en) Treatment methods using 17906 and uses therefor
WO2002054080A3 (en) Proteins, genes and their use for diagnosis and treatment of vascular response
WO2002053017A3 (en) Compositions and methods for the therapy, diagnosis and monitoring of breast cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties